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Paranasal sinusAbstract Alveolar-type rhabdomyosarcoma of head and neck region in adult is extremely rare. We
report a case of a 33-year-old lady who presented with persistent right unilateral nasal obstruction
and epistaxis for one months’ duration. Examination showed a fleshy, irregular-surfaced mass occu-
pying the whole right nasal cavity and histopathological examination revealed alveolar-type rhab-
domyosarcoma. Metastatic work-up showed pulmonary metastasis. After 3 months following
completion of four cycles of chemotherapy, a repeated scan showed significant shrinkage of the
tumor.
 2016 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Rhabdomyosarcoma is a malignant tumor that originates
from striated skeletal muscle, rarely occurring in the head
and neck region.1 Alveolar-type rhabdomyosarcoma, which
is the uncommon form, is more often encountered in teens
and young adults. Due to its aggressive growth and its deep-
seated locations, alveolar rhabdomyosarcomas are often
harder to treat effectively in adults, thus associated with a poor
prognosis.2. Case report
A 33-year-old lady presented with right unilateral nasal
obstruction and epistaxis for one month. She denied other sig-
nificant history. Nasoendoscopy revealed a fleshy, irregular
mass occupied the whole right nasal cavity (Fig. 1). There were
no palpable neck nodes. Contrast-enhanced imaging study
revealed a heterogeneous enhancing mass occupying the whole
right nasal cavity with lateral extension into the right maxillary
sinus. It extended posterosuperiorly to the right sphenoid sinus
and posteroinferiorly into the nasopharynx (Fig. 2). There was
no intracranial extension. Histopathological evaluation
showed a round to polygonal shaped cells with mildly pleo-
morphic darkly stained nuclei. The tumor cells were stained
positive for Myogenin, Desmin and CD56. Thus, it was inter-
preted as alveolar-type rhabdomyosarcoma. A subsequent
Figure 1 Endoscopic view of the right nasal cavity revealed an
irregular mass occupying the whole right nasal cavity which easily
bleeds on touch. S = septum, IT = right inferior turbinate,
F = floor of right nasal cavity.
178 S. Rajinder et al.metastatic evaluation revealed pulmonary metastasis. A diag-
nosis of alveolar-type rhabdomyosarcoma of nasal cavity
and paranasal sinus with clinical stage of T2N0M1 was made.
The patient was referred to an oncology center for further
management. Following the completion of four cycles of mul-
tiagent chemotherapy, a repeated scan was done during her
regular monthly follow up that showed significant shrinkage
of the tumor.Figure 2 Contrast-enhanced (axial) computed tomography revealed
nasal cavity with lateral extension into the right maxillary sinus po
nasopharynx (A, B). A coronal view (C, D) shows no intraorbital or3. Discussion
The incidence of alveolar-type rhabdomyosarcoma is predom-
inantly in childhood and it commonly occurs on the trunk or
extremities.1,2 An adult onset rhabdomyosarcoma of nasal
cavity and paranasal sinus is exceedingly rare occurrence with
only several cases reported in literature. However, only one
case reported with distant metastasis at time of diagnosis.3
In this case, during her first presentation to our center, the
patient was diagnosed with alveolar-type rhabdomyosarcoma
which had already metastasized to the lungs.
There are several types of rhabdomyosarcoma; the com-
monest type, the embryonal, accounts for about 75% and is
said to have a better prognosis. The alveolar-type constitutes
about 20% has a poorer prognosis.4 A recent study showed
that the commonest rhabdomyosarcoma arising from the
paranasal sinus is the alveolar-type.5
There is a wide spectrum of presentation based on the
involvement of the sinus or surrounding structures. In our cen-
ter, nasopharyngeal carcinoma is more prevalent, which was
what it was initially mistaken for. Our patient presented with
only typical localized nasal symptoms such as nasal obstruc-
tion and epistaxis with no other complaints. Apart from these
symptoms, patients may present with discharge, pain, and
swelling. Several literature reported ophthalmic presentations
such as proptosis, epiphora, diplopia, retro-orbital pain and
even orbital apex syndrome.3a huge heterogeneously enhancing mass occupying the whole right
sterosuperiorly to sphenoid sinus and posteroinferiorly into the
intracranial extension.
Figure 3 (A) Myogenin stain 4x objective showing positive staining within the tumor cells while the overlying respiratory epithelium and
stroma are negative. (B) Myogenin stain 40 objective showing specific diffuse nuclear positivity within the tumor cells while the vessel at
the center serves as negative internal control. (C) H&E stain 4 objective showing respiratory mucosa infiltrated by sheets of tumor cells
but sparing the overlying epithelial lining. (D) H&E stain 40 objective showing small round blue cell tumor morphology.
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tion, size and infiltration of the tumor.6 A contrast-enhanced
CT imaging is done to evaluate the primary tumor and further
define the surrounding vital structures as well as to look for
any bone erosion. It has been reported that tumors more than
5 cm in diameter have poorer prognosis.2 MRI was not done in
our center due to limited resources. Other metastatic evalua-
tion includes bone scan and abdominal ultrasound is done to
determine the staging.
Diagnosing rhabdomyosarcoma remains a challenge. His-
tology and immunochemistry is the sole method that leads to
a specific diagnosis which incorporates desmin and myogenin
staining.7 The diagnosis of alveolar-type rhabdomyosarcoma
is confirmed by microscopic visualization of small round rhab-
domyoblasts arranged in nests or cards separated by connec-
tive tissue trebaculae with focal areas of alveolar architecture.1
In recent years the outcome of rhabdomyosarcoma has
improved due to the availability of multimodal treatment for
this disease. The prognosis of this disease is dependent on
the stage at which it is presented. Surgical removal of the
tumor and chemotherapy or combination of both remains
the mainstay treatment. A complete resection is achieved by
resecting the tumor along with 0.5 cm rim of normal tissue
around it.2 Radiotherapy is reserved for patients who develop
recurrence following completion of initial treatment.8 The
duration of the chemotherapy is determined by the stage of
the disease at the time of presentation. Combinations of vin-
cristine, actinomycin-D and cyclophosphamide (VAC) are
the accepted chemotherapeutic agents.9 In recent years, the
use of brachytherapy in head and neck tumors has become
increasingly popular owing to its superiority in tissue-sparing
approach.10
4. Conclusion
Although alveolar-type rhabdomyosarcoma of nasal cavity
and paranasal sinus in adult is extremely uncommon, it shouldbe included in differential diagnosis. Metastasis needs to be
ruled out at time of diagnosis. Early diagnosis and prompt
treatment will improve outcome and increase survival rate.
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